Company / Operating Margin
Amgen Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
24.7%
FY2025
5-year range
21.7% / 36.3%
FY2021-FY2025
Trend
+13.8%
vs FY2024
Sector context
#18 of 133
Health Care
What the data says
Amgen's operating margin of 24.7% is higher than 86% of companies in the Health Care sector (FY2025). Operating Margin returned to growth in FY2025 after 2 years of decline, reaching 24.7%.
Based on SEC 10-K filings.
24.7% in FY2025 with a 5-year CAGR of -11.2%. Top quartile in the Health Care sector.
Declined from 28.0% to 24.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -11.6pp
- 5-Year Change
- -11.2pp
- 10-Year Change
- -
Sector benchmark
Top 14% in Health CareTop 14% of 133This company 24.7% Sector average -914.0%
▼
+102.7% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 13.8% year-over-year.
- Currently 938.7pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 24.7% | +13.8% |
| FY2024 | 21.7% | -22.5% |
| FY2023 | 28.0% | -22.9% |
| FY2022 | 36.3% | +23.6% |
| FY2021 | 29.4% | -18.2% |
| FY2020 | 35.9% | -13.2% |
| FY2019 | 41.4% | -4.2% |
| FY2018 | 43.2% | -1.0% |
| FY2017 | 43.6% | +2.5% |
| FY2016 | 42.6% | +9.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026